Table 2.
Clinical characteristics of the study participants
| Variables | Controls (n = 240) | Ischemic stroke (n = 259) | P-value |
|---|---|---|---|
| Age (mean ± SD, year) | 63.53 ± 10.48 | 64.66 ± 8.68 | 0.189 |
| Male/Female | 114/126 | 127/132 | 0.732 |
| BMI (mean ± SD, kg/m2) | 24.26 ± 2.42 | 24.09 ± 2.57 | 0.365 |
| Hypertension [n (%)] | 66(27.5) | 93(35.9) * | 0.044 |
| Diabetes [n (%)] | 18(7.5) | 34(13.1) * | 0.039 |
| Smoking [n (%)] | 47(19.6) | 72(36.3) * | 0.031 |
| Alcohol consumption [n (%)] | 42(17.5) | 65(25.1) * | 0.004 |
| Family history [n (%)] | 19(7.9) | 35(13.5) * | 0.044 |
| Atherosclerotic plaque [n (%)] | 160(66.7) | 195(75.3) * | 0.034 |
| Total cholesterol (mean ± SD, mmol/L) | 4.93 ± 0.69 | 5.02 ± 0.86 | 0.2 |
| Triglycerides (mean ± SD, mmol/L) | 1.73 ± 1.03 | 1.83 ± 0.78 | 0.22 |
| HDL-C (mean ± SD, mmol/L) | 1.34 ± 0.32 | 1.29 ± 0.37 | 0.108 |
| LDL-C (mean ± SD, mmol/L) | 2.68 ± 0.37 | 3.02 ± 0.81* | < 0.001 |
| tHcy (mean ± SD, µmol/L) | 10.05 ± 3.86 | 18.92 ± 5.87* | < 0.001 |